New Eli Lilly Weight-Loss Treatment Shows Strong Promise in Phase 3 Trial
Pharmaceutical giant Eli Lilly has revealed encouraging results from a Phase 3 trial of its newest weight-loss drug, retatrutide, offering…
Home »
Eli Lilly
Leerink Fuels Investor Optimism as Lilly Awaits Retatrutide Trial Readout
Eli Lilly has drawn renewed attention from the investment community as Leerink Partners reaffirmed its “Outperform” rating on the pharmaceutical…
Can GLP-1 Drugs Rewrite the Alzheimer’s Playbook, and Challenge Lilly’s Lead?
Eli Lilly’s recent market rally has been fueled largely by investor confidence in its Alzheimer’s disease portfolio, especially its monoclonal…
Lilly vs. Novo: The High-Stakes Race for the Future of Weight-Loss Drugs
As the GLP-1 drug market expands rapidly, two pharmaceutical giants are locked in a battle for dominance: Eli Lilly and…
Eli Lilly’s Amylin-Targeting Drug Delivers 20% Weight Loss in Mid-Stage Trial
Pharmaceutical company Eli Lilly has revealed compelling mid-stage data for its experimental weight-loss drug eloralintide, presenting a potential new weapon…
Eli Lilly Bets Big, Making Billions of Orforglipron Pills Ahead of FDA Nod
U.S. drugmaker Eli Lilly & Co. has already produced billions of doses of its investigational oral weight-loss pill in advance…
Eli Lilly Faces Mixed Reactions as GLP-1 Weight-Loss Trial Results Emerge
Eli Lilly has recently drawn attention in the pharmaceutical sector with its developments in GLP-1 receptor agonist therapies, designed to…
Investing in Weight Loss: Comparing Eli Lilly and Novo Nordisk Shares
The global obesity epidemic has created a lucrative market for pharmaceutical companies, drawing increasing attention from investors. In this competitive…
Eli Lilly Confirms Price of Mounjaro Remains Unchanged Despite Lower Medicine Content
Pharmaceutical company Eli Lilly has clarified that although it has introduced newly designed KwikPens for its injectable drug Mounjaro, the…
Eli Lilly Pauses Shipments of Mounjaro Ahead of Massive Price Hike
Pharmaceutical giant Eli Lilly has temporarily halted shipments of its popular weight-loss drug, Mounjaro, to the UK, citing skyrocketing demand…
